why choose us

Course: Elevating Myelofibrosis Care: Strategies for Risk Assessment, Treatment Innovations, and Care Excellence

CME Credits: 1.00

Released: 2026-03-06

This activity will equip hematology/oncology professionals with practical, evidence-based strategies to improve the care of patients with myelofibrosis (MF). Designed for a global, multidisciplinary audience, this live and enduring CME activity addresses critical gaps in the use of risk stratification tools, optimal selection and sequencing of emerging therapies, and integration of supportive care models. Through expert-led sessions on risk and symptom burden assessment, therapeutic advances, and team-based care, participants will gain the tools needed to deliver individualized, patient-centered treatment plans that improve outcomes and quality of life for those living with MF. This activity is derived from an independent satellite symposium at the Society of Hematologic Oncology 2025 Annual Meeting, originally held on September 3, 2025.


After completing this activity, the participant should be better able to:


View Full Course